文献速递肾移植慢性肾脏病肾血管病与高血压

活体肾捐献者肥胖问题:从风险到伦理的评估与管理差距

Obesity in Living Kidney Donors from Risk to Ethics: Bridging Gaps in Evaluation and Management.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-02-17

本文综述活体肾捐献者中肥胖的临床、伦理与流程挑战,指出肥胖与捐献后高血压、糖尿病、蛋白尿和慢性肾脏病相关但绝对风险有限,依赖BMI评估不足,倡导基于个体化风险和多学科管理的评估框架。

要点

  • 肥胖活体肾捐献者捐献后高血压、糖尿病、蛋白尿和慢性肾脏病风险增加但绝对风险有限。
  • 仅用BMI评估无法全面反映肥胖相关风险,导致选择标准不一致和潜在不公平。
  • 建议采用影像学脂肪评估等工具进行风险分层并个体化评估,强调多学科护理和捐献者咨询。

核心结论

  • 应转向基于个体化风险的活体肾捐献者评估,结合多学科护理和全面咨询,而非仅依赖BMI截断值。

研究设计与样本

  • 综述,探讨活体肾捐献者肥胖相关的病理生理机制、共病和捐献后结局证据及风险分层工具。

主要发现

  • 肥胖与捐献后高血压、糖尿病、蛋白尿和慢性肾脏病风险增加相关,但总体绝对风险有限,可能因代谢健康和脂肪分布而异。
  • 当前依赖BMI单独评估未能捕捉肥胖相关风险全谱,导致捐献者选择实践不一致和潜在不公平。
  • 影像学脂肪评估和个性化体重管理策略可用于更好风险分层,但减重后部分风险可能仍存在。

关键数值与推荐

  • 肥胖活体肾捐献者捐献后高血压、糖尿病、蛋白尿和慢性肾脏病风险增加但绝对风险有限。
  • 依赖BMI单独评估不足以全面反映肥胖相关风险。

临床怎么用

  • 临床应采用个体化、基于风险的评估方法,结合影像学脂肪评估和个性化体重管理,并加强捐献者咨询和多学科护理。

局限性

  • 综述未报告具体研究样本量、效应量或置信区间,证据多来自观察性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity is increasingly prevalent among living kidney donor candidates, presenting complex clinical, ethical, and logistical challenges. Although obesity is linked to increased post-donation hypertension, diabetes, proteinuria, and chronic kidney disease, the overall absolute risks are modest and may differ depending on metabolic health and patterns of fat distribution. Current reliance on body mass index alone fails to capture the full spectrum of obesity-related risks, leading to inconsistent donor selection practices and potential inequities. This review examines the pathophysiological mechanisms of obesity-related kidney injury and available evidence on comorbidities and postdonation outcomes related to obesity. We discuss tools for better risk stratification, such as imaging-based adiposity assessment and personalized weight management strategies, and note that some risks may remain after weight loss. Barriers such as rigid body mass index cutoffs, limited access to treatment, and lack of long-term follow-up exacerbate disparities in access to donation. We argue for a shift toward individualized, risk-based evaluation supported by multidisciplinary care. We underscore the importance of donor counseling and advocate for a comprehensive, rather than paternalistic approach to living kidney donor selection. Advancing safe and equitable living donation in the context of rising obesity rates will necessitate revised guidelines, improved access to treatment, and an ongoing commitment to donor well-being.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Budhiraja P, Bzoma B, Denic A, et al. Obesity in Living Kidney Donors from Risk to Ethics: Bridging Gaps in Evaluation and Management. Clin J Am Soc Nephrol. 2026. PMID: 41701547. doi:10.2215/CJN.0000001030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。